Biodesix (BDSX) Accumulated Expenses: 2019-2025
Historic Accumulated Expenses for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to $9.7 million.
- Biodesix's Accumulated Expenses rose 13.64% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year increase of 13.64%. This contributed to the annual value of $10.1 million for FY2024, which is 30.53% up from last year.
- Biodesix's Accumulated Expenses amounted to $9.7 million in Q3 2025, which was up 0.37% from $9.7 million recorded in Q2 2025.
- Biodesix's 5-year Accumulated Expenses high stood at $10.1 million for Q4 2024, and its period low was $5.7 million during Q1 2023.
- For the 3-year period, Biodesix's Accumulated Expenses averaged around $8.1 million, with its median value being $7.9 million (2024).
- In the last 5 years, Biodesix's Accumulated Expenses declined by 15.00% in 2022 and then skyrocketed by 37.60% in 2024.
- Biodesix's Accumulated Expenses (Quarterly) stood at $7.7 million in 2021, then increased by 7.21% to $8.2 million in 2022, then decreased by 6.18% to $7.7 million in 2023, then surged by 30.53% to $10.1 million in 2024, then rose by 13.64% to $9.7 million in 2025.
- Its Accumulated Expenses stands at $9.7 million for Q3 2025, versus $9.7 million for Q2 2025 and $7.4 million for Q1 2025.